PIK3CA and squamous cell neoplasm: We did not observe enough recurrent cases (2 relapses in 12 cases with PIK3CA mutations) to effectively evaluate the association between PIK3CA mutation status and RFS in the subgroups of patients with non-squamous cell tumors (shown in supplementary Figure S1A).